Loading insider details...
Latest Form 4 (Sep 21, 2026): Sale of 8,721 BBIO shares, $601.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 21, 2026 | BridgeBio Pharma, Inc. (BBIO) | Sale | 8,721 | $601.9K |
| Aug 20, 2026 | BridgeBio Pharma, Inc. (BBIO) | Sale | 1,900 | $154.2K |
| Aug 18, 2026 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 33,544 | n/a |
| Jun 18, 2026 | BridgeBio Oncology Therapeutics, Inc. (BBOT) | Grant/Award | 31,675 | n/a |
| Jun 8, 2026 | BridgeBio Pharma, Inc. (BBIO) | Sale | 2,200 | $144.6K |
| May 26, 2026 | BridgeBio Pharma, Inc. (BBIO) | Sale | 2,256 | $152.4K |
| May 19, 2026 | BridgeBio Pharma, Inc. (BBIO) | Exercise/Conversion | 33,544 | n/a |
| May 11, 2026 | BridgeBio Pharma, Inc. (BBIO) | Sale | 11,217 | $757.1K |
| Apr 13, 2026 | BridgeBio Pharma, Inc. (BBIO) | Sale | 7,200 | $530.2K |
| Mar 31, 2026 | Maze Therapeutics, Inc. (MAZE) | Grant/Award | 33,417 | n/a |